Cargando…
Tackling Multidrug Resistance in Streptococci – From Novel Biotherapeutic Strategies to Nanomedicines
The pyogenic streptococci group includes pathogenic species for humans and other animals and has been associated with enduring morbidity and high mortality. The main reason for the treatment failure of streptococcal infections is the increased resistance to antibiotics. In recent years, infectious d...
Autores principales: | Alves-Barroco, Cinthia, Rivas-García, Lorenzo, Fernandes, Alexandra R., Baptista, Pedro Viana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573253/ https://www.ncbi.nlm.nih.gov/pubmed/33123110 http://dx.doi.org/10.3389/fmicb.2020.579916 |
Ejemplares similares
-
Light Triggered Enhancement of Antibiotic Efficacy in Biofilm Elimination Mediated by Gold-Silver Alloy Nanoparticles
por: Alves-Barroco, Cinthia, et al.
Publicado: (2022) -
Siderophores as “Trojan Horses”: tackling multidrug resistance?
por: de Carvalho, Carla C. C. R., et al.
Publicado: (2014) -
Singularities of Pyogenic Streptococcal Biofilms – From Formation to Health Implication
por: Alves-Barroco, Cinthia, et al.
Publicado: (2020) -
Phylogenetic analysis and accessory genome diversity reveal insight into the evolutionary history of Streptococcus dysgalactiae
por: Alves-Barroco, Cinthia, et al.
Publicado: (2022) -
Nano-Strategies to Fight Multidrug Resistant Bacteria—“A Battle of the Titans”
por: Baptista, Pedro V., et al.
Publicado: (2018)